Company Description
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.
In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category.
Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners.
Hims & Hers Health, Inc. is based in San Francisco, California.
| Country | United States |
| Founded | 2017 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 1,637 |
| CEO | Andrew Dudum |
Contact Details
Address: 2269 Chestnut Street, Suite 523 San Francisco, California 94123 United States | |
| Phone | 415 851 0195 |
| Website | hims.com |
Stock Details
| Ticker Symbol | HIMS |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001773751 |
| CUSIP Number | 433000106 |
| ISIN Number | US4330001060 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Andrew Dudum | Co-Founder, Chairman and Chief Executive Officer |
| Oluyemi Okupe | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 3, 2025 | 10-Q | Quarterly Report |
| Nov 3, 2025 | 8-K | Current Report |
| Oct 31, 2025 | SCHEDULE 13G | Filing |
| Oct 27, 2025 | 144 | Filing |
| Oct 16, 2025 | 144 | Filing |
| Oct 14, 2025 | 144 | Filing |
| Oct 10, 2025 | 144 | Filing |
| Oct 2, 2025 | 8-K | Current Report |
| Oct 1, 2025 | 144/A | Filing |
| Oct 1, 2025 | 144 | Filing |